OLD Category: immuno-oncology
September 1, 2018 / Cancer Res.
Inhaled TLR9 Agonist Renders Lung Tumors Permissive to PD-1 Blockade by Promoting Optimal CD4+ and CD8+ T-cell Interplay
August 27, 2018 / Oncoimmunology
Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma
August 21, 2018 / Can. Immunol. Res.
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
August 21, 2018 / Can. Immunol. Res.
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
August 20, 2018 / Nature Med.
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
August 15, 2018 / J Immunol.
IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy
August 13, 2018 / Nature Commun.
Pan-cancer deconvolution of tumour composition using DNA methylation
August 1, 2018 / Oncoimmunology
Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor
July 23, 2018 / Cancer Immunol. Immunother.